ROP vs ZYME · P/E 41, rev $1.88B vs rev $76.3M
Roper Technologies, Inc. (ROP) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
ROP currently screens at market cap $61.61B and trailing P/E 41.3. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the ROP and ZYME stock pages for the full models.
Not investment advice.